You searched for "prostatic"

473 results found

Day-case monopolar and bipolar transurethral resection of the prostate

The aim of this study was to assess the safety and efficacy of performing monopolar (mTURP) and bipolar transurethral resection of prostate (bTURP) as a day-case. This was a prospective two-centre study. One centre performed day-case mTURP (group M) and...

Aqua Medical: LATP Prostate Biopsy with Perino-Flex

Join renowned urologist Mr Ahmed Ali & Colleagues for an intensive hands-on LATP (Local Anesthesia Transperineal) Training Course featuring the groundbreaking Pernio-Flex, the world’s first prostate biopsy guide with angulation. Designed for urology professionals eager to enhance biopsy precision and patient comfort, this course covers every aspect of LATP technique using Pernio-Flex’s innovative design, which enables precise angulation for improved accuracy and accessibility

Prostate Cancer UK: Towards Equity: Exploring Prostate Cancer Disparities Experienced by Black Men - data and evidence mini conference (Free)

We will delve into why Prostate Cancer UK is exploring health inequalities, starting with Black men and highlight valuable research findings and challenges in health inequalities space, with keynote speaker Dr Tom Cowling, who will share his insights from the latest England and Wales NPCA State of the Nation Report, including sociodemographic and tumour data from England. From 1.30 pm - 4.30pm

Announcing a new specialist distributor of medical devices for prostate cancer

Healthcare Supply Solutions are a new distributor focussed on medical devices for the diagnosis and management of Prostate Cancer.

Urological Cancer Management

This was all in all a pretty good read. It covers a wide range of topics authoritatively and with a degree of confidence that allows for quite a focused discussion on a range of malignancies from adrenal glands to penile...

Increased use of active surveillance for men with intermediate risk prostate cancer

The optimal management of men with intermediate risk prostate cancer remains unclear and continues to be debated. The authors interrogate the US National Cancer Database for 176,122 men diagnosed with intermediate risk prostate cancer between 2010 and 2016. Of these...

Call for standardised reporting of adverse events

This article will be of immense benefit to all of us involved in mortality and morbidity meetings and Clinical Governance, especially registrars and junior members of the team. The authors present data from the UK, USA and Europe. In prostate...

Prostate cancer and an electronic nose

So far the transrectal ultrasound guided (TRUS) biopsy has been the ‘gold standard’ for diagnosing prostate cancer. However, it is invasive and can lead to complications, so there is a need for new non-invasive diagnostic tools to avoid unnecessary biopsy...

MRI scans and cardiac devices

There is an increasing use of MRI in many urological disorders e.g. prostate cancer and renal cancer. Many patients with cardiac pacemakers or implantable cardioverter defibrillators (ICD) are denied access to MRI scans due to safety concerns. MRI is given...

Nomograms – is it hide and seek?

Everyday new decision-making aids are being developed due to various advances in software technology. This article from the UK makes very interesting reading. The word ‘nomogram’ is derived from the Greek word translated as ‘law line’ or ‘alignment chart’. The...

Orchid: fighting male cancer for over 25 years

Orchid was established in 1996 by a young testicular cancer patient, Colin Osborne MBE, and the oncologist who saved his life, Professor Tim Oliver MD, FRCP. The charity exists to save men’s lives from testicular, penile, and prostate cancers and...

Characteristics of APC and the usefulness of MP-MRI for diagnosis

The authors evaluated the pathological and oncological characteristics of anteriorly located prostate cancer (APC) in 728 RP specimens, and the accuracy of multiparametric magnetic resonance imaging (MP-MRI) for APC evaluation. Patients were characterised as APC (70% or more of tumour...